Holdings in Company

Paris, France and Camberley, UK – 2 December 2020 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that it was notified on 1 December 2020 that, as at 30 November 2020 BlackRock Inc.’s holding in the Company on a voting and capital basis is 3.54% (2,500,373 shares). http://novacyt.com/wp-content/uploads/2020/12/Novacyt-BlackRock-holdings-02.12.2020.pdf

Visit Page

Launch of new private sector testing service

Novacyt, an international specialist in clinical diagnostics, announces the launch of a new service, known as VersaLab™, to support private sector testing of infectious diseases, initially focused on COVID-19.

Visit Page

Director/PDMR Shareholding

Paris, France and Camberley, UK – 18 November 2020 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that it has been notified that, on 12 November 2020, Anouska Penny-Gibson, a person closely associated (PCA) to Steve Gibson, a PDMR of Novacyt, acquired 697 ordinary shares of €1/15 each in

Visit Page